Skip to main content
SpringerLink
Log in

Introduction and Overview of Cancer Therapeutics

  • Chapter
  • First Online:
Therapeutic Approaches in Cancer Treatment

Part of the book series: Cancer Treatment and Research ((CTAR,volume 185))

Abstract

Cancer is a complex disease. According to the Globocan survey, 63% deaths are due to cancer. There are some conventional methods that are used to treat cancer. However, certain treatment modalities are under clinical trials still. The success of treatment depends on type and stage of cancer, locality, and patient’s response to that specific treatment. Most widely used treatments are surgery, radiotherapy, and chemotherapy. Personalized treatment approach has some promising effects, yet some of the points are still unclear. This chapter has provided the overview of some of the therapeutic modalities; however, the therapeutic potential has been discussed in details throughout the book.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Ames BN, Gold LS, Willett WC (1995) The causes and prevention of cancer. Proc Natl Acad Sci USA 92(12):5258–5265. https://doi.org/10.1073/pnas.92.12.5258

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Anel M, Steller E, Esus J et al (2000) Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents. N Engl J Med 343:1350–1354

    Article  Google Scholar 

  3. M Arruebo N Vilaboa B Sáez-Gutierrez J Lambea A Tres M Valladares Á González-Fernández (2011) Assessment of the evolution of cancer treatment therapies. Cancers 3(3):3279–3330. https://doi.org/10.3390/cancers3033279

  4. Bhosle J, Hall G (2009) Principles of cancer treatment by chemotherapy. Surgery 27(4):173–177. https://doi.org/10.1016/j.mpsur.2009.01.006

    Article  Google Scholar 

  5. Burrell R, McGranahan N, Bartek J et al (2013) The causes and consequences of genetic heterogeneity in cancer evolution. Nature 501:338–345. https://doi.org/10.1038/nature12625

    Article  CAS  PubMed  Google Scholar 

  6. Burrell R, McGranahan N, Bartek J et al (2013b) The causes and consequences of genetic heterogeneity in cancer evolution. Nature 501:338–345. https://doi.org/10.1038/nature12625

  7. Chargaria C, Giraudb T, Lacorneriec T, Cosset JM (2022) Prevention of radiation-induced cancers. Cancer/Radiothérapie 26(1–2):92–95. https://doi.org/10.1016/j.canrad.2021.09.005

  8. Caine GJ, Stonelake PS, Rea D, Lip GYH (2003) Coagulopathic complications in breast cancer. Cancer 98(8):1578–1586. https://doi.org/10.1002/CNCR.11702

    Article  PubMed  Google Scholar 

  9. Carmeliet P, Jain R (2011) Molecular mechanisms and clinical applications of angiogenesis. Nature 473:298–307. https://doi.org/10.1038/nature10144

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Carmeliet P, Jain R (2011) Molecular mechanisms and clinical applications of angiogenesisno title. Nature 473:298–307. https://doi.org/10.1038/nature10144

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Chang DK, Hohenforst W, Wu H-C, Chang D-K, Huang C-T (2013) Targeted-therapy for cancer related papers. J Cancer Mol

    Google Scholar 

  12. Chatterjee DK, Fong LS, Zhang Y (2008) Nanoparticles in photodynamic therapy: an emerging paradigm. Adv Drug Deliv Rev 60(15):1627–1637. https://doi.org/10.1016/j.addr.2008.08.003

    Article  CAS  PubMed  Google Scholar 

  13. DeBerardinis RJ, Lum JJ, Hatzivassiliou G, Thompson CB (2008) The Biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab 7(1):11–20. https://doi.org/10.1016/j.cmet.2007.10.002

    Article  CAS  PubMed  Google Scholar 

  14. DeVita VT, Chu E (2008) A history of cancer chemotherapy. Can Res 68(21):8643–8653. https://doi.org/10.1158/0008-5472.CAN-07-6611

    Article  CAS  Google Scholar 

  15. Early Breast Cancer Trialists’ Collaborative Group (EBCTCG) (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365(9472):1687–1717

    Article  Google Scholar 

  16. Elion GB, Singer S, Hitchings GH (1954) Antagonists of nucleic acid derivatives. J Biol Chem 208(2):477–488. https://doi.org/10.1016/s0021-9258(18)65573-5

    Article  CAS  PubMed  Google Scholar 

  17. Hall EJ (2006) Intensity-modulated radiation therapy, protons, and the risk of second cancers. Int J Radiat Oncol* Biol* Phys 65 (1):1–7. https://doi.org/10.1016/j.ijrobp.2006.01.027

  18. Farber S, Diamond LK, Mercer RD, Sylvester Jr RF, Wolff JA (1948) Temporary remissions in acute leukemia in children produced by folic acid antagonist, 4-aminopteroyl-glutamic acid (aminopterin). N Engl J Med 238(23):787–793. https://www.nejm.org/doi/full/https://doi.org/10.1056/NEJM192802231980115

  19. Fogh SE, Andrews DW, Glass J, Curran W, Glass C, Champ C, Evans JJ et al (2010) Hypofractionated stereotactic radiation therapy: an effective therapy for recurrent high-grade gliomas. J Clin Oncol 28(18):30–48

    Article  Google Scholar 

  20. Gilman A (1946) Therapeutic applications of chemical warfare agents. Fed Proc 5:285–292. https://www.semanticscholar.org/paper/Therapeutic-applications-of-chemical-warfare-Gilman/57644fe19040136a57deca51c078ffd672b93666#paper-header

  21. Gupta T, Agarwal J, Jain S, Phurailatpam R, Kannan S, Ghosh-Laskar S, Murthy V et al (2012) Three-dimensional conformal radiotherapy (3D-CRT) versus intensity modulated radiation therapy (IMRT) in squamous cell carcinoma of the head and neck: a randomized controlled trial. Radiother Oncol 104 (3): 343–48. https://doi.org/10.1016/j.radonc.2012.07.001

  22. Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144(5):646–674. https://doi.org/10.1016/j.cell.2011.02.013

    Article  CAS  PubMed  Google Scholar 

  23. Hanly AM, Hayanga A, Winter DC, Bouchier-Hayes DJ (2005) Thrombomodulin: tumour biology and prognostic implications. Eur J Surg Oncol (EJSO) 31(3):217–220. https://doi.org/10.1016/J.EJSO.2004.11.017

  24. Hassen-Khodja R (2004) Gamma knife and linear accelerator stereotactic radiosurgery. Agence d’évaluation Des Technologies et Des Modes d’intervention En Santé

    Google Scholar 

  25. Heidelberger C, Chaudhuri NK, Danneberg P, Mooren D, Griesbach L, Duschinsky R, Schnitzer RJ, Pleven E, Scheiner J (1957) Title: fluorinated pyrimidines, a new class of tumour-inhibitory compounds. Nature 179:663–666. https://doi.org/10.1038/179663a0

  26. Hozumi N, Tonegawa S (1976) Evidence for somatic rearrangement of immunoglobulin genes coding for variable and constant regions. Proc Natl Acad Sci USA 73(10):3628–3632. https://doi.org/10.1073/pnas.73.10.3628

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Huang X, Jain PK, El-Sayed IH et al (2008) Lasmonic photothermal therapy (PPTT) using gold nanoparticles. Lasers Med Sci 23(217). https://doi.org/10.1007/s10103-007-0470-x

  28. Jensen SB, Jarvis V, Zadik Y, Barasch A, Ariyawardana A, Hovan A, Yarom N, Lalla RV, Bowen J, Elad S (2013) Systematic review of miscellaneous agents for the management of oral mucositis in cancer patients. Support Care Cancer 21(11):3223–3232. https://doi.org/10.1007/s00520-013-1884-6

    Article  PubMed  Google Scholar 

  29. Johnson IS, Armstrong JG, Gorman M, Paul Burnett J (1963) The vinca alkaloids: a new class of oncolytic agents. Can Res 23(77):1390–1427

    CAS  Google Scholar 

  30. Kano H, Flickinger JC, Tonetti D, Hsu A, Yang HC, Flannery TJ, Niranjan A, Dade Lunsford L (2017) Estimating the risks of adverse radiation effects after gamma knife radiosurgery for arteriovenous malformations. Stroke 48(1):84–90. https://doi.org/10.1161/STROKEAHA.116.014825

    Article  CAS  PubMed  Google Scholar 

  31. Kantelhardt EJ, Vetter M, Schmidt M, Veyret C, Augustin D, Hanf V, Meisner C et al (2011) Prospective evaluation of prognostic factors UPA/PAI-1 in node-negative breast cancer: phase III NNBC3-Europe trial (AGO, GBG, EORTC-PBG) comparing 6 × FEC versus 3 × FEC/3 × Docetaxel. BMC Cancer 11(1):1–10. https://doi.org/10.1186/1471-2407-11-140

  32. Li MC, Hertz R, Bergenstal DM (1958) Therapy of choriocarcinoma and related trophoblastic tumors with folic acid and purine antagonists. N Engl J Med 259(2):66–74

    Article  CAS  PubMed  Google Scholar 

  33. Lum JJ, Bauer DE, Kong M, Harris MH, Li C, Lindsten T, Thompson CB (2005) Growth factor regulation of autophagy and cell survival in the absence of apoptosis. Cell 120(2):237–248. https://doi.org/10.1016/j.cell.2004.11.046

    Article  CAS  PubMed  Google Scholar 

  34. Moore P, Chang Y (2010) Why do viruses cause cancer? Highlights of the first century of human tumour virology. Nat Rev Cancer 878–889. https://doi.org/10.1038/nrc2961

  35. Moore PS, Feng H, Chang Y, Shuda M (2008) Clonal integration of a polyomavirus in human merkel cell carcinoma. Science 319(5866):1096–1100

    Google Scholar 

  36. Nakamura N, Shikama N, Oguchi M (2010). Intensity-modulated radiation therapy (IMRT). Jpn J Clin Med 68(6):1035–1039

    Google Scholar 

  37. Oshiro Y, Takeda Y, Hirano S, Ito H, Aruga T (2011) Role of radiotherapy for local control of asymptomatic adrenal metastasis from lung cancer. Am J Clin Oncol Cancer Clin Trials 34(3):249–253. https://doi.org/10.1097/COC.0b013e3181dbb727

    Article  Google Scholar 

  38. Pardal R, Clarke M, Morrison S (2003) Applying the principles of stem-cell biology to cancer. Nat Rev Cancer 3:895–902

    Article  CAS  PubMed  Google Scholar 

  39. Pavlova NN, Thompson CB (2016) The emerging hallmarks of cancer metabolism. Cell Metab 23(1):27–47. https://doi.org/10.1016/j.cmet.2015.12.006

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Pearson OH, Eliel LP, Rawson RW, Dobriner K, Rhoads CP (1949) This study was undertaken to determine whether the rate of growth of various types of neoplastic tissues in man would be influenced by increasing adrenal cortical function. In: Kendall (n.d.) “Cancer-November 1949-Pearson-Acth‐and Cortisone‐induced regression of Lymphoid tumors in man”. A preliminary report

    Google Scholar 

  41. Picot J, Cooper K, Bryant J, Clegg AJ (2011) The clinical effectiveness and cost-effectiveness of bortezomib and thalidomide in combination regimens with an alkylating agent and a corticosteroid for the first-line treatment of multiple myeloma: a systematic review and economic evaluation. https://doi.org/10.3310/hta15410

  42. Ralph SJ, Rodríguez-Enríquez S, Neuzil J, Saavedra E, Moreno-Sánchez R (2010) The causes of cancer revisited: ‘mitochondrial malignancy’ and ROS-induced oncogenic transformation-why mitochondria are targets for cancer therapy Mol Aspects Med 31(2):145–170. https://doi.org/10.1016/j.mam.2010.02.008

  43. Raty JK, Pikkarainen JT, Wirth T, Yla-Herttuala S (2008) Gene therapy: the first approved gene-based medicines, molecular mechanisms and clinical indications. Curr Mol Pharmacol 1(1):13–23

    Google Scholar 

  44. Rehman S, Abbas Z (2018) An overview of cancer treatment modalities. https://doi.org/10.5772/intechopen.76558

  45. Rodgers GM, Becker PS, Blinder M, Cella D, Chanan-Khan A, Cleeland C, Coccia PF et al (2012) Cancer-and chemotherapy-induced anemia. J Natl Compr Canc Netw 10(5):628–653. https://doi.org/10.6004/jnccn.2012.0064

  46. Shi J, Votruba AR, Farokhzad OC, Langer R (2010) Nanotechnology in drug delivery and tissue engineering: from discovery to applications. Nano Lett 10(9):3223–3323

    Google Scholar 

  47. Shojaei F (2012) Anti-angiogenesis therapy in cancer: current challenges and future perspectives. Cancer Lett 320(2):130–137. https://doi.org/10.1016/j.canlet.2012.03.008

    Article  CAS  PubMed  Google Scholar 

  48. Timmerman RD, Xing L (2012) Image-guided and adaptive radiation therapy. Lippincott Williams & Wilkins

    Google Scholar 

  49. Wagner A, Ploder O, Enislidis G, Truppe M, Ewers R (1995) Virtual image guided navigation in tumor surgery—technical innovation. J Cranio-Maxillofac Surg 23(5):271–273. https://doi.org/10.1016/S1010-5182(05)80155-6

    Article  Google Scholar 

  50. Wang M, Thanou M (2010) Targeting nanoparticles to cancer. Pharmaological Res 62(2):90–99

    Article  CAS  Google Scholar 

  51. Xing RH, Rabbani SA (1999) Transcriptional regulation of urokinase (uPA) gene expression in breast cancer cells: role of DNA methylation. Int J Cancer 81:443–450. https://doi.org/10.1002/(SICI)1097-0215(19990505)81:3

    Article  CAS  PubMed  Google Scholar 

  52. Zhang L, Gu FX, Chan JM, Wang AZ, Langer RS, Farokhzad OC (2007) Nanoparticles in medicine: therapeutic applications and developments. Clin Pharmacol Theapeutics 83(5):761–769

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Biologial Sciences, National University of Medical Sciences (NUMS), PWD, Islamabad, Pakistan

    Asma Saleem Qazi

Authors
  1. Asma Saleem Qazi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Asma Saleem Qazi .

Editor information

Editors and Affiliations

  1. Department of Biological Sciences, National University of Medical Sciences, Rawalpindi, Pakistan

    Asma Saleem Qazi

  2. Respiratory Medicine, Castle Hill Hospital, Cottingham, UK

    Kanwal Tariq

Rights and permissions

Reprints and permissions

Copyright information

© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Qazi, A.S. (2023). Introduction and Overview of Cancer Therapeutics. In: Qazi, A.S., Tariq, K. (eds) Therapeutic Approaches in Cancer Treatment. Cancer Treatment and Research, vol 185. Springer, Cham. https://doi.org/10.1007/978-3-031-27156-4_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-27156-4_1

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-27155-7

  • Online ISBN: 978-3-031-27156-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation